In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Researchers have successfully disrupted the hepatitis B virus's ability to infect human liver cells in the laboratory using a ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells ...

The trial was tailored to evaluate the therapy at multiple ascending dose levels, with three dose administrations per level.

The genetically modified animal model could lead to new treatments for the global disease Lauren Rust, Ph.D., assistant staff ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...

MASH is the most severe form of MASLD. Hepatitis B or hepatitis C. Medicines for these diseases can prevent further damage to your liver. Other conditions that can lead to cirrhosis include ...

New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high-risk patients. Study: AGA Clinical Practice Guideline on the Prevention and ...

Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases, today announced that ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...